Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-041594
Filing Date
2018-08-02
Accepted
2018-08-02 12:41:44
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv498952_10q.htm 10-Q 548930
2 EXHIBIT 31.1 tv498952_ex31-1.htm EX-31.1 9127
3 EXHIBIT 31.2 tv498952_ex31-2.htm EX-31.2 9262
4 EXHIBIT 32.1 tv498952_ex32-1.htm EX-32.1 5419
  Complete submission text file 0001144204-18-041594.txt   4128925

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arth-20180630.xml EX-101.INS 788687
6 XBRL TAXONOMY EXTENSION SCHEMA arth-20180630.xsd EX-101.SCH 42910
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arth-20180630_cal.xml EX-101.CAL 22769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arth-20180630_def.xml EX-101.DEF 283531
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arth-20180630_lab.xml EX-101.LAB 299013
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arth-20180630_pre.xml EX-101.PRE 352866
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 18987390
SIC: 3841 Surgical & Medical Instruments & Apparatus